Understand the source comparison
Semax Amidate Popular in Nootropics | Type Comparison
Semax Amidate (N-Acetyl-Semax) High. Acetyl group blocks aminopeptidase cleavage at N-terminus Moderate-to-high. Increased lipophilicity aids passive diffusion 4–6 hours intranasal Cognitive enhancement, focus, BDNF upregulation Gold standard for nootropic res
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Semax Amidate (N-Acetyl-Semax)
- High. Acetyl group blocks aminopeptidase cleavage at N-terminus
- Moderate-to-high. Increased lipophilicity aids passive diffusion
- 4–6 hours intranasal
- Cognitive enhancement, focus, BDNF upregulation
- Gold standard for nootropic research. Stability and bioavailability make it the only practical form for reproducible CNS effects
- Unmodified Semax (ACTH 4-10 fragment)
- Very low. Degraded by plasma peptidases within 15–30 minutes
- Low. Hydrophilic structure limits membrane crossing
- <30 minutes
- Research only. Not viable for therapeutic use
- Degrades too rapidly for meaningful CNS activity; acetylation is non-negotiable for real-world application
- Semax with C-terminal modifications
- Variable. Depends on specific modification (amidation increases stability moderately)
- Low-to-moderate. C-terminal changes don't address lipophilicity as effectively as N-acetylation
- 1–3 hours
- Experimental analogs in pre-clinical research
- Less common than N-acetylated forms; improvements in stability don't offset reduced BBB penetration compared to acetylated versions